LevelJump Announces 2026 Q1 Financial Results
Rhea-AI Summary
LevelJump Healthcare (JMPHF) reported first quarter 2026 revenues of $4.7 million, up from $4.58 million in Q1 2025, a 2.7% year-over-year increase. The company recorded a net loss of $375,923 and reported EBITDA of $194,468 for Q1 2026.
LevelJump’s 100%-owned subsidiary, Canadian Teleradiology Services, generated EBITDA of $624,311 in the quarter. Management highlighted the use of non-IFRS measures such as adjusted EBITDA for evaluating operating performance and liquidity, while advising investors to consider these alongside IFRS metrics.
Positive
- Revenue growth to $4.7 million in Q1 2026, up 2.7% year over year
- Consolidated EBITDA of $194,468 in Q1 2026
- Subsidiary EBITDA of $624,311 at Canadian Teleradiology Services in Q1 2026
Negative
- Net loss of $375,923 in Q1 2026 despite higher revenues
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the quarter ended March 31, 2026.
Financial and Operational Highlights
Revenues were
$4.7 million in the first quarter of 2026 compared to$4.58 million in revenues for the first quarter of 2025, a year over year revenue increase of2.7% .Canadian Teleradiology Services, Inc., the Company's
100% owned subsidiary had EBITDA of$624,311 in the first quarter of 2026.
2026 Financial Results for first quarter
Revenues of
$4.7 million in Q1 2026 with a net loss of$375,923 .EBITDA of
$194,468 in Q1 2026.
Non-IFRS Financial Measures
This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity.
For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Interim Condensed Consolidated Financial Statements for the quarter ended March 31, 2026, which are available on the Company's website (www.leveljumphealthcare.com) and under the Company's profile on SEDAR+ (www.sedarplus.ca).
About LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
Mitchell Geisler
Chief Executive Officer
info@leveljumphealthcare.com
647-340-2020
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305202